The absence of MyD88 in knockout models prevented TI-mediated inflammatory cell recruitment within the tumor microenvironment, consequently impairing tumor suppression and T cell-derived INF-γ production, collectively establishing the essential role of the MyD88 pathway in BCG’s anti-tumor immunity (129) (Figure 1). The gene discussed is MYD88; the disease is neoplasm.